# US 2013/0158504 A1 · System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0158504 A1
- Document ID: US20130158504A1
- Status: Published application
- Kind: A1
- Application number: 13/714,545
- Filed: 2012-12-14
- Published: 2013-06-20
- Earliest claimed: 2011-12-16
- Assignees: ICU Medical, Inc.
- Inventors: Timothy L. Ruchti; Mohammad M. Khair
- Web page: https://patentgrep.com/patent/US20130158504A1

## CPC

- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/4839: {combined with drug delivery}
- G16H 20/17: delivered via infusion or injection
- G16H 40/67: for remote operation
- G16H 50/30: for calculating health indices; for individual health risk assessment
- G16H 50/50: for simulation or modelling of medical disorders
- G16Z 99/00: Subject matter not provided for in other main groups of this subclass
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16Z: INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR

## Abstract

A system and method for monitoring and delivering medication to a patient includes a controller that has a control algorithm and a closed loop control that monitors the control algorithm. A sensor is in communication with the controller and monitors a medical condition. A rule base application in the controller receives data from the sensor and the closed loop control and compares the data to predetermined medical information to determine the risk of automation of therapy to the patient. The controller then provides a predetermined risk threshold where below the predetermined risk threshold automated closed loop medication therapy is provided. If the predetermined risk threshold is met or exceeded, automated therapy adjustments may not occur and user/clinician intervention is requested.

## Claims

### Claim 1

A system for delivering medication to a patient, the system comprising:
a controller having a control algorithm and an automation risk monitor that monitors the control algorithm;
an electronic medication delivery device controlled by the controller;
a sensor in communication with the controller and the automation risk monitor and monitoring a medical condition;
a rule based application in the automation risk monitor that receives data from the sensor and the closed loop control and compares the data to predetermined medical information to determine a risk of therapy automation to the patient; and
wherein the controller controls the medication delivery device to deliver medication to the patient based on a comparison of the risk to a predetermined risk threshold.

### Claim 2 (depends on 1)

The system of claim 1 wherein when the risk is below the predetermined risk threshold additional automated medication delivery therapy is provided and when the risk at or above the predetermined risk threshold the controller triggers a request for user intervention.

### Claim 3 (depends on 2)

The system of claim 2 wherein triggering a request for user intervention causes the closed loop control to function as an open loop.

### Claim 4 (depends on 2)

The system of claim 2 wherein the additional automated medication delivery therapy includes delivering insulin.

### Claim 5 (depends on 1)

The system of claim 1 wherein the medical condition is a glucose level of the patient.

### Claim 6 (depends on 1)

The system of claim 1 wherein the predetermined medical information includes a risk matrix.

### Claim 7 (depends on 6)

The system of claim 6 wherein the risk matrix includes information pertaining to glucose ranges, glucose change, insulin change and risk level.

### Claim 8 (depends on 1)

The system of claim 1 wherein the predetermined medical information includes information determined using continuous mapping functions, fuzzy logic or probability calculations.

### Claim 9 (depends on 1)

The system of claim 1 wherein the predetermined medical information includes information determined using a mathematical model.

### Claim 10 (depends on 9)

The system of claim 9 wherein the mathematical model is defined by one of a pharmacokinetic and a pharmacodynamic model.

### Claim 11 (depends on 2)

The system of claim 2 wherein the request for user intervention is sent to the user through a messaging system.

### Claim 12 (depends on 6)

The system of claim 6 wherein a portion of the risk matrix is user customizable.

### Claim 13 (depends on 12)

The system of claim 12 wherein the user customizable portion of the risk matrix includes a plurality of user-defined risk levels and respective actions are associated with the risk levels and wherein at least two of the respective actions are different.

### Claim 14 (depends on 13)

The system of claim 13 wherein the plurality of user-defined risk levels includes at least three risk levels comprising high, medium and low risk levels.

### Claim 15

A method for monitoring and delivering medication to a patient comprising:
monitoring a control algorithm of a controller for delivering medication from an electronic medication delivery device with an automation risk monitor;
receiving data at the controller from a sensor regarding a medical condition;
comparing the data from the control algorithm and sensor to predetermined medical information to determine a risk of therapy automation to the patient;
comparing the risk of therapy automation to a predetermined risk threshold; and
delivering medication to the patient as automated medication therapy based on the comparison of the risk of therapy automation to the predetermined risk threshold.

### Claim 16 (depends on 15)

The method of claim 15 further comprising the step of providing additional automated medication delivery therapy when the risk is below the predetermined risk threshold.

### Claim 17 (depends on 16)

The method of claim 16 wherein the automated medication delivery therapy includes delivering insulin.

### Claim 18 (depends on 15)

The method of claim 15 further comprising the step of triggering a request for user intervention when the risk is at or above the predetermined threshold to cause a closed loop control to function as an open loop.

### Claim 19 (depends on 15)

The method of claim 15 wherein the medical condition is a glucose level of the patient.

### Claim 20 (depends on 15)

The method of claim 15 wherein the predetermined medical information includes a risk matrix.

### Claim 21 (depends on 20)

The method of claim 20 wherein the risk matrix includes information pertaining to glucose ranges, glucose change, insulin change and risk level.

### Claim 22 (depends on 15)

The method of claim 15 wherein the predetermined medical information includes information determined using continuous mapping functions, fuzzy logic or probability calculations.

### Claim 23 (depends on 15)

The method of claim 15 wherein the predetermined medical information includes information determined using a mathematical model.

### Claim 24 (depends on 23)

The method of claim 23 wherein the mathematical model is defined by one of a pharmacokinetic and a pharmacodynamic model.

### Claim 25 (depends on 15)

The method of claim 15 wherein the request for user intervention is sent to the user through a messaging system.

### Claim 26 (depends on 20)

The method of claim 20 wherein a portion of the risk matrix is user customizable and includes at least three risk levels comprising high, medium and low risk levels with respective actions associated therewith and at least two of the respective actions are different.
